According to a new report published by UnivDatos Markets Insights, the Companion Diagnostics Market is expected to grow at a CAGR of around 16% from 2021-2027. The analysis has been segmented into indication (breast cancer, lung cancer, colorectal cancer, gastric cancer, and others); technology (real-time-polymerase chain reactions, gene sequencing, fluorescence in situ hybridization, and...